Cancer Genetics, Inc. (CGIX) Social Stream
Cancer Genetics Inc (CGIX) Price Targets From Analysts
Use the tables below to see what analysts covering Cancer Genetics Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 8, 2018
CGIX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Cancer Genetics Inc's number of analysts covering the stock is higher than nearly none of all US stocks.
- Cancer Genetics Inc's variance in analysts' estimates is less than almost 100% of all US stocks.
- Cancer Genetics Inc's upside potential (average analyst target price relative to current price) is greater than 99.13% of all US stocks.
- The average analyst price target of CGIX is higher than 96.87% of stocks in the micro market cap category.
Make investment decisions regarding CGIX using the data that counts. Try POWR Ratings for free.